Integra LifeSciences
IART
IART
277 hedge funds and large institutions have $4.71B invested in Integra LifeSciences in 2022 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 112 increasing their positions, 91 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.7% less ownership
Funds ownership: 91.4% → 89.7% (-1.7%)
9% less capital invested
Capital invested by funds: $5.16B → $4.71B (-$449M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
277
Holding in Top 10
1
Calls
$10.2M
Puts
$7.96M
Top Buyers
| 1 | +$18.1M | |
| 2 | +$14.8M | |
| 3 | +$14.6M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$11M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$9.94M |
Top Sellers
| 1 | -$149M | |
| 2 | -$90M | |
| 3 | -$29.9M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$17.8M |
| 5 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$17.3M |